New Prescription for the Spanish Drug Sector Fernando AntoñanzasPedro Gómez Editorial 18 October 2012 Pages: 977 - 980
An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions Phill O’NeillNancy J. Devlin Short Communication 18 October 2012 Pages: 987 - 993
Methods of Model Calibration Douglas C. A. TaylorVivek PawarMilton C. Weinstein Short Communication 18 October 2012 Pages: 995 - 1000
Cost Effectiveness of Pharmacogenomics William B. WongJosh J. CarlsonDavid L. Veenstra Review Article 18 October 2012 Pages: 1001 - 1013
Economic Implications of Sleep Disorders Tracy L. SkaerDavid A. Sclar Review Article 18 October 2012 Pages: 1015 - 1023
Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV Teresa L. KaufRaymond A. FarkouhMike G. Chambers Original Research Article 18 October 2012 Pages: 1025 - 1039
Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy Mario EandiLorenzo PradelliGiuseppe Pontoriero Original Research Article 18 October 2012 Pages: 1041 - 1054
Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses A Decision Tree Model Edward C. F. Wilson Original Research Article 18 October 2012 Pages: 1055 - 1064